Search

Search Constraints

You searched for: Author/Creator Fabbri, Maria Agnese

Search Results

1. A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study. Issue 2 (1st February 2019)

2. Adjuvant Aromatase Inhibitor Therapy in Early Breast Cancer: What Factors Lead Patients to Discontinue Treatment?. Issue 5 (September 2015)

3. Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab. Issue 4 (3rd April 2018)

4. ESAS and FACT-B in eribulin-treated metastatic breast cancer patients: a multicenter, prospective and observational study. (July 2017)

5. PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting. (November 2021)